Skip to Content

Corticotropin Pregnancy and Breastfeeding Warnings

Corticotropin is also known as: ACTH, Acthar, H.P. Acthar Gel

Medically reviewed by Last updated on Aug 1, 2018.

Corticotropin Pregnancy Warnings

FDA pregnancy category: C

Use during pregnancy when the potential benefits outweigh the potential risks to the fetus.

Corticotropin has shown to have embryocidal effects. There are no controlled data in human pregnancy.

FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Corticotropin Breastfeeding Warnings

A decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Excreted into human milk: Unknown
Excreted into animal milk: Unknown

The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Acthar (corticotropin)." Rhone-Poulenc Rorer, Collegeville, PA.

References for breastfeeding information

  1. "Product Information. Acthar (corticotropin)." Rhone-Poulenc Rorer, Collegeville, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.